Emoxypine (Mexidol)

A vitamin B6 derivative with powerful antioxidant and anxiolytic properties, widely prescribed in Russia and Eastern Europe for anxiety, cognitive impairment, and cerebrovascular disease. Emoxypine inhibits lipid peroxidation, modulates GABA-A and benzodiazepine binding sites, and improves cerebral blood flow. It provides anxiolytic effects similar to benzodiazepines without sedation, tolerance, or addiction.

Dosage

Standard: 125-375 mg daily in 2-3 divided doses. Commonly 125 mg twice daily. Take with food. Effects are noticeable within 30-60 minutes. Russian clinical practice uses 4-6 week courses.

Dosages shown are for research reference only. Always consult a qualified healthcare provider.

Half-Life

2-2.6 hours

Administration

Oral (tablets). Also available as IV/IM injection in clinical settings. Mexidol is the brand name.

Shop Emoxypine (Mexidol)

99%+ purity · third-party lab tested

Browse →

Mechanism of Action

Emoxypine (2-ethyl-6-methyl-3-hydroxypyridine succinate) has a 3-hydroxypyridine structure similar to vitamin B6 (pyridoxine). It is one of the most potent inhibitors of lipid peroxidation in brain tissue — it scavenges hydroxyl radicals and peroxyl radicals, inhibits Fe2+-induced lipid peroxidation, and may chelate transition metals. It modulates the GABA-benzodiazepine receptor complex (GABA-A), enhancing GABAergic transmission through positive allosteric modulation — possibly at a site distinct from the classical benzodiazepine binding site, explaining the lack of sedation and tolerance. It improves mitochondrial function (Complex I protection, membrane stabilization), stabilizes cell membranes (reducing fluidity changes during oxidative stress), and enhances cerebral microcirculation (possibly via nitric oxide or prostaglandin modulation). The anxiolytic mechanism may involve partial agonism or different subunit selectivity.

Regulatory Status

Prescription medication in Russia, Ukraine, and several CIS countries. Not approved by FDA or EMA. Available as supplement/research compound elsewhere.

Risks & Safety

Common

Mild nausea, drowsiness, dry mouth.

Serious

Limited Western safety data. Allergic reactions reported.

Rare

Elevated blood pressure, emotional lability.

Compare Emoxypine (Mexidol) With

Research Papers

10
Mexidol, Cytoflavin, and succinic acid derivatives as antihypoxic, anti-ischemic metabolic modulators, and ergogenic aids in athletes and consideration of their potential as performance enhancing drugs.

Published: December 24, 2024

AI Summary

The conjugation of emoxypine with succinate elevates the therapeutic effectiveness of the Mexidol formulation as succinic acid itself has important impacts to consider despite being a common food additive and drug excipient.

Unauthorized ingredients in "nootropic" dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents.

Published: August 24, 2023

AI Summary

Several are authorized DS ingredients in the United States resulting in significant global variability as to what qualifies as a legal nootropic. Synergistic combinations, excessive dosing, or recently researched pharmacology may justify listing certain nootropics as doping agents or warrant additional attention in future regulations.

[Combined administration of mexidol with known medicines].

Published: June 3, 2019

AI Summary

It enhances therapeutic effects of a variety of drugs in research and clinical settings, boosts the effectiveness of therapy prescribed in accordance with the applicable federal standards and contributes to reducing the severity of complications.

[The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis].

Published: January 23, 2024

AI Summary

To conduct a meta-analysis of the effectiveness of Mexidol therapy in patients with chronic brain ischemia (CBI) and cognitive disorders (CD).

[The effect of rubomycin, mexidol and emoxypine on some metabolic indexes and the proccess of spontaneous metastasis under conditions of experimental neoplasia].

Published: April 3, 2007

AI Summary

The effects of mexidol and emoxypine on some indexes of endotoxicosis and weighted characteristics of tumor carrier during experimental neoplasia have been studied under the conditions of therapy using antracycline antibiotic rubomycin.

[Efficacy of Mexidol in combination with cerebral revascularization in the treatment of ischemic stroke].

Published: March 21, 2024

AI Summary

The review covers adverse influence oxidative stress at the cerebral ischemia and reperfusion periodes of ischemic stroke. The results of preclinical studies demonstrating the ability of Mexidol to neutralize the effects of free radicals and activate antioxidant protection are presented.

[A modern concept of antihypoxic and antioxidant effects of mexidol].

Published: March 4, 2018

AI Summary

The results of the indirect antioxidant activity of mexidol, manifested in the increased expression under the ischemia of the transcription factor Nrf2, responsible for the cell resistance to oxidative stress are presented. The results of preclinical and clinical studies confirming the antioxidant and antihypoxic effects of mexidol are summarized.

[Efficacy of Mexidol in the correction of postcovid syndrome in patients with chronic cerebrovascular diseases].

Published: June 15, 2023

AI Summary

To evaluate the effectiveness of sequential therapy with Mexidol and Mexidol FORTE 250 in the correction of postcovoid syndrome (PKS) in patients with chronic cerebrovascular diseases (CVD).

[Experience with mexidol in neurological practice].

Published: November 30, 2018

AI Summary

Antihypoxic, antioxidant and nootropic effects of mexidol contribute to the improvement of patients with cerebrovascular pathology. The results of clinical studies show that the sequential scheme of using mexidol (first i.v. or i.m., then per os) is effective in the complex therapy of ischemic disea

[The possibilities of Mexidol usage in neuropediatrics].

Published: November 9, 2023

AI Summary

Mexidol (ethylmethylhydroxypyridine succinate) is a modern neurometabolic medication increasingly being used in neuropediatrics. Taking into account the unique multimodal action of Mexidol, it seems promising to expand the range of indications for its application in neuropediatrics, based on the results of new clinical trials organized in accord...

Frequently Asked Questions

What is Emoxypine (Mexidol) used for?

A vitamin B6 derivative with powerful antioxidant and anxiolytic properties, widely prescribed in Russia and Eastern Europe for anxiety, cognitive impairment, and cerebrovascular disease. Emoxypine inhibits lipid peroxidation, modulates GABA-A and benzodiazepine binding sites, and improves cerebral blood flow. It provides anxiolytic effects similar to benzodiazepines without sedation, tolerance, or addiction.

What are the side effects of Emoxypine (Mexidol)?

Common: Mild nausea, drowsiness, dry mouth. Serious: Limited Western safety data. Allergic reactions reported. Rare: Elevated blood pressure, emotional lability.

How is Emoxypine (Mexidol) administered?

Emoxypine (Mexidol) is administered via oral (tablets). also available as iv/im injection in clinical settings. mexidol is the brand name..

What is the half-life of Emoxypine (Mexidol)?

The half-life of Emoxypine (Mexidol) is 2-2.6 hours.

Related Nootropics

5-HTP

5-Hydroxytryptophan is the immediate precursor to serotonin, derived from the seeds of Griffonia simplicifolia. By providing the rate-limiting intermediate in serotonin synthesis, 5-HTP effectively raises brain serotonin levels. Used for mood support, anxiety, sleep, and appetite control. More effective than L-Tryptophan because it bypasses the rate-limiting enzyme step.

Mood & AnxietySleep & Recovery

Agmatine Sulfate

A metabolite of L-arginine produced by decarboxylation. Agmatine is an endogenous neuromodulator that acts on multiple receptor systems — it blocks NMDA receptors, activates imidazoline receptors, inhibits nitric oxide synthase, and modulates opioid signaling. This makes it useful for neuropathic pain, mood, stress resilience, and as a complement to other nootropics. Also enhances insulin sensitivity and nitric oxide production.

Mood & AnxietyNeuroprotection

ALCAR

Acetyl-L-Carnitine is an acetylated form of L-Carnitine that crosses the blood-brain barrier more effectively than regular L-Carnitine. In the brain, it donates its acetyl group for acetylcholine synthesis and supports mitochondrial fatty acid oxidation for energy. Used clinically for age-related cognitive decline, depression, and diabetic neuropathy.

MitochondrialMood & AnxietyNeuroprotection

Aniracetam

A fat-soluble racetam roughly 5-10x more potent than Piracetam by weight. Known for its anxiolytic (anti-anxiety) properties alongside cognitive enhancement — a combination that makes it popular for social situations and creative work. It modulates both glutamate and dopamine/serotonin systems, giving it a unique mood-lifting quality that other racetams lack.

RacetamsMood & Anxiety

Ashwagandha

An Ayurvedic adaptogen used for over 3,000 years that has become one of the most popular and well-studied supplements for stress, anxiety, and cognitive function. Ashwagandha (Withania somnifera) significantly reduces cortisol levels, improves stress resilience, and enhances memory and reaction time. KSM-66 and Sensoril are the two most studied standardized extracts.

AdaptogensMood & Anxiety

B-Complex

The B vitamins (B1, B2, B3, B5, B6, B9, B12) are essential coenzymes in brain energy metabolism, neurotransmitter synthesis, and methylation reactions. Deficiency in any B vitamin impairs cognitive function. B12 and folate deficiency specifically cause irreversible neurological damage if untreated. A high-quality B-complex is foundational for any nootropic regimen, particularly for vegetarians, older adults, and those under chronic stress.

NeuroprotectionMood & Anxiety